Updates matching "National"

Advocates are pushing Congress to increase cancer research funding at that National Institutes of Health (NIH), National Cancer Institute (NCI) and to fund the president’s proposal to create the Advanced Research Project on Health (ARPA-H) as part of the FY 2022 federal budget.

The Food and Drug Administration (FDA) today authorized the marketing of two low-nicotine cigarettes as “modified risk tobacco products,” including one product that is menthol-flavored.

The American Cancer Society Cancer Action Network is celebrating the 50 th anniversary of President Richard Nixon’s signing of the National Cancer Act into law. The law, which took effect December 23, 1971, transformed the nation’s approach to preventing, detecting, and treating the disease.

The majority of cancer patients in the United States say they struggle to afford the costs of their cancer care.

The U.S. Food and Drug Administration (FDA) opposed public health groups’ request that the agency provide regular status reports to a U.S. District Judge and estimate the dates it expects to complete its review of applications for products that rank among the top 10 brands in market share.

The American Cancer Society Cancer Action Network (ACS CAN) announces three new members and the newly-elected leadership officers to the Board of Directors, with all terms beginning on January 1, 2022.

A new survey offers insight into how a national paid family and medical leave program could benefit cancer patients and survivors who struggle with missed work and lost income due to their illness.

Washington, D.C. – The U.S. District Court in the Southern District of California will hear oral arguments Thursday in a lawsuit brought by the African American Tobacco Control Leadership Council (AATCLC), Action on Smoking and Health (ASH) and the American Medical Association (AMA), claiming that the Food and Drug Administration’s

More than 150 organizations representing patients, providers and health equity advocates sent a letter to Congress today urging them to pass the Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act into law.